Sentry’s Head of Industry Relations published in Pharmacy Times
Lisa Scholz, PharmD, FACHE, Sentry’s Head of Industry Relations, has written a two-part article for Pharmacy Times about transparency in the 340B program. This second part, which has been published in the March issue, discusses the call for greater program transparency and why it’s important that transparency goes both ways.
Lisa has been an expert on the 340B program throughout her career, having previously served as both the vice president of the HRSA Pharmacy Services Support Center at the American Pharmacists Association and as the chief operating officer and senior vice president at 340B Health.